PharmaShots Weekly Snapshots (Apr 26 – 30, 2021)

 PharmaShots Weekly Snapshots (Apr 26 – 30, 2021)

PharmaShots Weekly Snapshots (Apr 26 – 30, 2021)

BMS Reports the US FDA’s Acceptance of Opdivo’s sBLA for Priority Review to Treat Muscle Invasive Urothelial Carcinoma

Published: Apr 30, 2021 | Tags: BMS, US, FDA, Opdivo, sBLA, Priority Review, nivolumab, Muscle Invasive Urothelial Carcinoma

Janssen Reports MAA Submission to EMA for Cilta-cel to Treat Relapsed/ Refractory Multiple Myeloma

Published: Apr 30, 2021 | Tags: Janssen, MAA, Submission, EMA, Cilta-cel, Relapsed/ Refractory, Multiple Myeloma

Repertoire Collaborates with Yale University to Identify Novel Antigen and T- Cell Receptor for Multiple Sclerosis

Published: Apr 30, 2021 | Tags: Repertoire, Yale University, Antigen, T- Cell Receptor, Multiple Sclerosis

Celltrion Reports Results of Regdanvimab (CT-P59) in Pre-Clinical Study Against the South African Variant (B.1.351)

Published: Apr 30, 2021 | Tags: Celltrion, Results, Regdanvimab, CT-P59, Pre-Clinical, Study, South African Variant, B.1.351

Innovent Reports First Patient Dosing in P-II Trial of IBI302 for Neovascular Age-Related Macular Degeneration

Published: Apr 30, 2021 | Tags: Innovent, First Patient, Dosing, P-II, Trial, IBI302, Neovascular Age-Related Macular Degeneration

Alphamab and Pfizer Initiate P-II Trial Evaluating KN046 + Inlyta (axitinib) as a 1L Treatment of Non-Small Cell Lung Cancer

Published: Apr 30, 2021 | Tags: Alphamab, Pfizer, Initiate, P-II, Trial, KN046, Inlyta, axitinib, Non-Small Cell Lung Cancer

Angion and Vifor Pharma Report Completion of Patient Enrollment in P-II AKI-002-15 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury

Published: Apr 29, 2021 | Tags: Angion, Vifor Pharma, Completion, Patient Enrollment, P-II, AKI-002-15 Study, ANG-3777, Cardiac-Surgery, Acute Kidney Injury

Alcon to Acquire Exclusive US Commercialization Rights to Novartis’ Simbrinza

Published: Apr 29, 2021 | Tags: Alcon, Exclusive, US, Commercialization Rights, Novartis, Simbrinza

BeiGene Reports Results of Brukinsa (zanubrutinib) in P-III Head-to-Head APSEN Trial for R/R Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Published: Apr 29, 2021 | Tags: BeiGene, Results, Brukinsa (zanubrutinib), P-III, APSEN Trial, R/R Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

BioMarin Collaborates with Allen Institute to Develop Gene Therapies for Rare Brain Diseases

Published: Apr 29, 2021 | Tags: BioMarin, Allen Institute, Develop, Gene Therapies, Rare Brain Diseases

Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India

Published: Apr 29, 2021 | Tags: Organicell, Expansion, Trial, Zofin, Treat, COVID-19, India

Pfizer Acquires Amplyx to Expand its Infectious Disease Portfolio

Published: Apr 29, 2021 | Tags: Pfizer, Amplyx, Expand, Infectious Disease

Voluntis Collaborates with Eisai to Develop Digital Therapeutics for Oncology Patients

Published: Apr 28, 2021 | Tags: Voluntis, Eisai, Develop, Digital Therapeutics, Oncology

LogicBio Signs an Option Agreement with Canbridge to Develop Gene Editing Therapies

Published: Apr 28, 2021 | Tags: LogicBio, Option Agreement, Canbridge, Develop, Gene Editing Therapies

InveniAI Collaborates with Shionogi on AI-Based Drug Discovery

Published: Apr 28, 2021 | Tags: InveniAI, Shionogi, AI-Based, Drug Discovery

Y-mAbs Reports MAA Submission to EMA for Omburtamab to Treat Pediatric Patients with CNS/Leptomeningeal Metastasis from Neuroblastoma

Published: Apr 28, 2021 | Tags: Y-mAbs, MAA, Submission, EMA, Omburtamab,  CNS/Leptomeningeal Metastasis, Neuroblastoma

Abbott Launches AI-Powered Coronary Imaging Platform in Europe

Published: Apr 28, 2021 | Tags: Abbott, Launches, AI-Powered, Coronary Imaging Platform, Europe

The US FDA Grants Priority Review to Takeda’s Mobocertinib (TAK-788) for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

Published: Apr 28, 2021 | Tags: US, FDA, Priority Review, Takeda, Mobocertinib, TAK-788, EGFR Exon20 Insertion, Metastatic, Non-Small Cell Lung Cancer

Glenmark’s Ryaltris Nasal Spray Receives EC’s Approval as 1L Treatment for Allergic Rhinitis

Published: Apr 27, 2021 | Tags: Glenmark, Ryaltris Nasal Spray, EC, Approval, Treatment, Allergic Rhinitis

Daiichi Sankyo Expands its Collaboration with Esperion to Additional Territories

Published: Apr 27, 2021 | Tags: Daiichi Sankyo, Expands, Esperion, Additional, Territories

Pieris Out-licenses PRS-342 to Boston Pharmaceuticals for ~$363M

Published: Apr 27, 2021 | Tags: Pieris, Out-licenses, PRS-342, Boston Pharmaceuticals,  ~$363M

I-Mab Reports Results of Olamkicept (TJ301) in P-II Study for Ulcerative Colitis

Published: Apr 27, 2021 | Tags: I-Mab, Results, Olamkicept, TJ301, P-II Study, Ulcerative Colitis

Medtronic Collaborates with Surgical Theater to Provide Augmented Reality Platform to Neurosurgery

Published: Apr 27, 2021 | Tags: Medtronic, Surgical Theater, Augmented Reality Platform, Neurosurgery

Biocon Biologics and Viatris Receive European Commission Approval for Abevmy (biosimilar, bevacizumab)

Published: Apr 27, 2021 | Tags: Biocon Biologics, Viatris, European Commission, Approval, Abevmy

AstraZeneca’s Tagrisso (osimertinib) Receives EU’s CHMP Positive Opinion for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer

Published: Apr 26, 2021 | Tags: AstraZeneca, Tagrisso, osimertinib, EU, CHMP, Positive Opinion, Early-Stage, EGFR-Mutated Lung Cancer

AstraZeneca and MSD’s Selumetinib Receive EU’s CHMP Positive Opinion as the First Therapy for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas

Published: Apr 26, 2021 | Tags: AstraZeneca, MSD, Selumetinib, EU, CHMP, Positive Opinion, First Therapy, Neurofibromatosis Type 1 Plexiform Neurofibromas

Sanofi and AstraZeneca Report Results of Nirsevimab in P-III MELODY Study for the Protection of Healthy Infants Against Respiratory Syncytial Virus Disease

Published: Apr 26, 2021 | Tags: Sanofi, AstraZeneca, Results, Nirsevimab, P-III, MELODY Study, Respiratory Syncytial Virus Disease

Dermavant Presents Results of Tapinarof in Two P-III Trials for the Treatment of Psoriasis at AAD2021

Published: Apr 26, 2021 | Tags: Dermavant, Results, Tapinarof, Two, P-III, Trials, Psoriasis

GSK’s Jemperli (dostarlimab) Receives the EC’s Approval for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer

Published: Apr 26, 2021 | Tags: GSK, Jemperli, dostarlimab, EC, Approval, Recurrent, Advanced, dMMR/MSI-H, Endometrial Cancer

BMS Presents Results of Deucravacitinib in Two P- III Trials for Moderate to Severe Plaque Psoriasis at AAD2021

Published: Apr 26, 2021 | Tags: BMS, Results, Deucravacitinib, Two, P- III Trials, Moderate, Severe, Plaque Psoriasis

Related Post: PharmaShots Weekly Snapshots (Apr 19 – 23, 2021)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post